#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glioblastoma multiforme Idiopathic pulmonary fibrosis Epileptic encephalopathy Waldenstrom's macroglobulinaemia recurrent Staphylococcal infection Cholangiosarcoma Osteosarcoma Liver transplant rejection Rosai-Dorfman syndrome Parkinson's disease Oesophageal adenocarcinoma stage II Small intestine neuroendocrine tumour Spina bifida Glomerulonephritis chronic Skin angiosarcoma More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment VEXAS syndrome – Diagnostics Fragile X syndrome – Life with Disease Mantle cell lymphoma – Trials in Disease Breast angiosarcoma – Life with Disease Haemophilia A with anti factor VIII – Treatment Cystic fibrosis Haemolytic uraemic syndrome – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Vascular malformation – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iti-1284 Staphylococcus Aureus OXYBUTYNIN HYDROCHLORIDE Propafenone Hydrochloride L-Tyrosine Autologous Pancreatic Islets Filgrastim Linagliptin Meldonium Immunoglobulins, Normal Human Metoprolol Flecainide Insulin Glargine Vinflunine Xenon Brimonidine CEFTAROLINE FOSAMIL Sibeprenlimab Selpercatinib Ptg-Carcik-Cd19 More therapies…

    Learn about Your Condition

    Lichen planopilaris Retinal vein occlusion Urinary incontinence Appendicitis Atrophic vulvovaginitis Polymyalgia rheumatica Essential hypertension Gallbladder cancer Syphilis Infantile apnoea Neonatal asphyxia Staphylococcal infection Rectosigmoid cancer Head and neck cancer stage IV Sleep disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pneumonia bacterial

  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • POLYMYXIN B SULFATE
    • Rifabutin
    • Ampicillin Sodium
    Croatia Greece

  • A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • Saline
    Greece Hungary Italy

  • Study evaluating blood biomarkers for diagnosis and monitoring treatment in patients with pulmonary tuberculosis using isoniazid, rifampicin, pyrazinamide, and ethambutol combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Ethambutol Hydrochloride
    • Isoniazid
    • Pyrazinamide
    Spain

  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefotaxime
    • Ceftriaxone Sodium
    • Cefuroxime Axetil
    Belgium The Netherlands

  • Study on Nebulized Amikacin for Treating Ventilator-Associated Gram-Negative Pneumonia in Patients on Veno-Arterial ECMO

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Amikacin Sulfate
    • Cefepime Hydrochloride
    • Piperacillin Sodium
    France

  • Safety and tolerability study of bacteriophage cocktail TP-122A given by inhalation in adults with ventilator-associated pneumonia

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Demerecviridae Bacteriophage Against Klebesiella Pneumoniae (113.073 Bp)
    • Drexlerviridae Bacteriophage Against Klebesiella Pneumoniae (45.423 Bp)
    • Myoviridae Bacteriophage Against Klebesiella Pneumoniae (169.802 Bp)
    The Netherlands Portugal
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!